4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001140361-15-014293
CIK 0001009356operating
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 11:43 AM ET
Size
7.3 KB
Accession
0001140361-15-014293
Insider Transaction Report
Form 4
CREECH TIMOTHY J
See Remarks
Transactions
- Disposition to Issuer
Common Stock
2015-04-01$173.00/sh−21,372$3,697,356→ 0 total - Disposition from Tender
Common Stock
2015-04-01$173.00/sh−4,065$703,245→ 0 total
Footnotes (2)
- [F1]Shares tendered for an offer price of $173.00 per share in cash, subject to any applicable withholding taxes, pursuant to the tender offer consummated on April 1, 2015 pursuant to the terms of the Agreement and Plan of Merger, dated as of February 20, 2015 (as amended, the "Merger Agreement"), by and among the Issuer, Valeant Pharmaceuticals International ("VPI"), a Delaware corporation and a wholly owned subsidiary of Valeant, Sun Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of VPI, and solely for purposes of guaranteeing VPI's and Merger Sub's obligations under the Merger Agreement, Valeant Pharmaceuticals International, Inc. ("Valeant"), a British Columbia corporation.
- [F2]Pursuant to the terms of the Merger Agreement, on April 1, 2015, each share of the Issuer's restricted stock issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) was converted into the right to receive $173.00 per share in cash, subject to any applicable withholding taxes.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 11:43 AM ET
- Size
- 7.3 KB